Rapid health technology assessment of baloxavir marboxil in the treatment of influenza / 中国药房

OBJECTIVE To evaluate the effectiveness， safety and economy of baloxavir marboxil in the treatment of influenza， and to provide evidence-based reference for the introduction of new drugs in hospitals and clinical medication decisions. METHODS Retrieved from PubMed， Embase， Web of Science， Cochrane Library， Epistemonikos， CBM， CNKI， VIP， Wanfang database， official websites and relevant databases of health technology assessment （HTA） institutions， the results of the included studies were descriptively analyzed after literature screening， data extraction and quality evaluation. RESULTS A total of 11 studies were included， involving 6 systematic reviews/meta-analyses and 5 pharmacoeconomic studies. Compared with placebo， baloxavir marboxil significantly shortened the time to alleviation of symptoms （TTAS） and time to resolution of fever （TTRF）， reduced the virus titer change from baseline at 24 h and 48 h after treatment and the incidence of bronchitis， with statistical significance （P＜ 0.05）. Compared with neuraminidase inhibitors （NAIs）， there were no significant differences in shortening TTRF and reducing the incidence of complications， pneumonia and bronchitis （P＞0.05）. The majority of studies suggested that there were no significant differences in shortening TTAS （P＞0.05）. Only very low-quality literature suggested that baloxavir marboxil could significantly reduce the virus titer change from baseline at 24 h and 48 h after treatment. In terms of safety， the incidences of adverse events （AEs） and drug-related adverse events （DRAEs） induced by baloxavir marboxil showed no significant differences， compared with peramivir and zanamivir （P＞0.05）. Some studies considered that the incidences of AEs and DRAEs with baloxavir marboxil were lower than placebo， oseltamivir and laninamivir. Compared with oseltamivir in China and laninamivir in Japan， baloxavir marboxil showed cost-effectiveness advantages. CONCLUSIONS Compared with placebo， baloxavir marboxil has good efficacy， safety and economy. Compared with NAIs （oseltamivir）， baloxavir marboxil has good economic advantages in China， but further high-quality studies are still needed regarding its safety and efficacy.

Treatment analysis and pharmaceutical care for one child with bacterial meningitis / 药学实践杂志

Objective To explore the strategies of drug treatment and pharmaceutical care for children with bacterial meningitis. Methods The anti-infective therapy, therapeutic drug monitoring and dose adjustment of vancomycin in children with bacterial meningitis were analyzed and discussed according to relevant guidelines and literatures. Results Clinical pharmacists analyzed therapeutic regimen. According to the results of etiology and drug sensitivity, meropenem was discontinued and rifampicin was added. Based on drug monitoring of vancomycin, it is suggested to extend the infusion time of vancomycin to reach the target concentration. The child was discharged from hospital. Conclusion Recommendations of the relevant drug treatment guidelines and the latest medical research evidence should be provided by clinical pharmacists in order to promote reasonable and effective clinical uses of medicine.

Determination of Voriconazole in Human Plasma by HPLC / 中国药房

OBJECTIVE:To establish a method for the concentration determination of voriconazole in human plasma.METHODS:Plasma samples were precipitated with acetonitrile.Using ketoconazole as internal standard,HPLC method was adopted.The determination was performed on Dionex U-3000 Dimonsil C18 column with mobile phase consisted of triethylamine-glacial acetic acid-water mixed solution (1 ∶ 1∶98,V/V/V,pH was about 4.0)-acetonitrile (40∶60,V/V) at the flow rate of 1.0 mL/min.The detection wavelength was set at 255 nm.The column temperature was 40 ℃,and sample size was 20 μL.RESULTS:The linear range of voriconazole was 0.2-20.0 μg/mL.The limits of quantification was 0.2 μg/mL,and the minimum detection limit was 0.03 μg/mL.RSDs of inter-day and intra-day were lower than 10％.The method recoveries were 92.06％-106.26％ (RSD＜5％,n=5),and extraction recoveries were 75.62 ％-90.59 ％ (RSD ＜ 5 ％,n=5).The plasma concentration of voriconazole in 10 children ranged 0.22-4.90 μg/mL (n =10).CONCLUSIONS:The method is simple,rapid,specific and can be used for drug monitoring of voriconazole.

Determination of polyblend miscibility by dilute-solution viscometry / 中国组织工程研究

BACKGROUND: Polyblends composed of thermoplastic polyurethane elastomer (TPU) and bisphenol A type of polysulfone (PSF) or polymethyl methacrylate (PMMA) can improve the properties of TPU, bisphenol A type of polysulfone or PMMA and can widen the scope of application. The property of polyblends bad or good depends on the miscibility of polyblends. The dilute-solution viscometry (DSV) is a simple and rapid way for determining the miscibility for polyblends. The study on the determination of miscibility for TPU/PSF and TPU/PMMA polyblends by the DSV has not been reported up to now. OBJECTIVE: To differentiate the miscibility of TPU/PSF polyblend and that of TPU/PMMA polyblend, and at the same time to verify the consistency of μ and α criteria in the determination of polyblend miscibility by DSV.DESIGN: Observation and contrast analysis based on the two polyblend systems.SETTING: Chemical Engineering and Pharmaceutics College, Henan University of Science and Technology.MATERIALS: TPU sample was purchased from Luoyang Jiming Chemical Industry Limited Company, China. PSF sample was purchased from the First Plastic Factory of Dalian, China. PMMA sample was synthesized by our laboratory. N, N-dimethylformamide was provided by Beijing Chemical Plant.METHODS:This study was performed at the Key Laboratory of Polymer Science and Nano-technology, Henan University of Science and Technology in May 2006. The different molar ratio of TPU / PSF and TPU / PMMA polyblends were prepared in N, N-dimethylformamide. An ubbelohde dilution viscometer (whose inner diameter was between 0.5 mm and 0.6 mm) was employed for measuring the relative viscosities of the polymer solutions in DMF at (25±0.01) ℃. The second stop-clock was used to record efflux time. From the efflux time, the relative viscosities could be obtained. Then the specific viscosities could be given by the relative viscosities value. From a series of relative viscosities, the specific viscosities and other data of two polyblends, μ values and α values of two polyblends were obtained.MAIN OUTCOME MEASURES: The efflux time of two polyblend solutions in an ubbelohde viscometer.RESULTS: The μ and α values of TPU/PSF polyblend were all above zero, which showed that TPU/PSF polyblend was miscible. But the μ and α values of TPU/PMMA polyblend were all below zero, which showed that TPU/PMMA polyblend was immiscible. CONCLUSION:The μ criterion is consistent with the α criterion in judging for polyblend miscibility. DSV method is simple, and it can be used in the determination of polyblend miscibility.

Research of Mild Hypothermia on Expression of AKT after Hypoxia-Ischemia Brain Damage / 医学研究杂志

Objective To study the effect of local mild hypothermia on AKT protein expression after rats focal cerebral ischemia-reperfusion injury.Methods By using the model of rat focal cerebral ischemia-reperfusion injury,the middle cerebral arteries(MCA)of SD rats were occluded for 2 h,and reperfused for2h,12h,24h,72h.Immunohistochemical analysis was used to detect expression of AKT.Results AKT expressed after ischemia 2h,the expression was significantly increased after ischemia reperfusion with peak expression at 72h in model group on normal temperature.In mild hypothermia group,the AKT expression was higher than that in normal temperature group when at the same time point.Conclusion Brain hypoxia-ischemia could induce the expression of AKT.Mild hypothermia could promote the expression of AKT.The expression of AKT could be one of the protected way of brain hypoxia-ischemia.

Analysis of Clinical Drug Use and Adverse Drug Reactions in Children's Hospital / 中国药房

OBJECTIVE:To evaluate the characteristics and regularity of adverse drug reactions (ADR) in children's hospital. METHODS:The clinical drug use and ADR of 3 653 children during 2006～2008 in our hospital were analyzed statistically by designing a child medication registration form. RESULTS:The incidence of 498 ADR cases was about 13.63%; ADR were mostly occurred in 1～3 year-old children(36.14%); 71.29% were caused by intravenously; 66.87% were induced by antibiotics; ADR were more common in spring and winter. CONCLUSION:The drugs have a dual nature. Moreover,children belong to a special group. The measures such as strictly mastering clinical indications,reducing irrational drug use,sufficient therapy and avoiding or reducing the occurrence of ADR can guarantee children grow healthily.